Cover Image

Osteopathic Manipulative Treatment: A Safe and Feasible Adjunct in Sickle Cell Disease Pain Management

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Amber Brown, Derrick Goubeaux, Seethal A. Jacob, Jennifer A. Belsky
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pediatric Blood & Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Neighborhood Disadvantage on Preventive and Acute Care Utilization in Sickle Cell Disease
by: Ashley Catanzarite, et al.
Published: (2024)

Safety and Tolerability of Intravenous Lidocaine Infusions as Opioid Adjunct for Children Hospitalized With Sickle Cell Vaso‐Occlusive Pain
by: Ugochukwu Agbakwuru, et al.
Published: (2024)

Sickle Cell Story Club: Implementation of a Clinic‐Based Literacy Promotion Program
by: Julia E. LaMotte, et al.
Published: (2025)

Current Treatment Strategies and Supportive Care Practices in the Care of Children and Adolescents With Mature B‐Cell Non‐Hodgkin Lymphoma: A Survey of Children's Oncology Group Institutions
by: Jennifer A. Belsky, et al.
Published: (2025)

Screening and Impact of Neuropathic Pain in Young Individuals With Sickle Cell Disease
by: Amira Adly, et al.
Published: (2024)

Treatment Experience Using a Micro‐Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease
by: Ashwin Patel, et al.
Published: (2025)

Sickle Cell Disease and Hemoglobin S Prevalence in Botswana
by: Setho Ruth Taboka Kgakatsi, et al.
Published: (2025)

Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease
by: Keli D. Coleman, et al.
Published: (2025)

Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study
by: Suhei C. Zuleta De Bernardis, et al.
Published: (2026)

Statewide Academic Performance of High School Students With Sickle Cell Disease
by: Andrew M. Heitzer, et al.
Published: (2025)

Successful Treatment of Bone Marrow Necrosis and Fat Embolism Syndrome Without Long‐Term Sequelae in a Young Adult with Sickle Cell Disease: A Case Report and Recommendations for Diagnosis and Management
by: Chelsea L. Haynes, et al.
Published: (2025)

Delayed Presentation of Transfusion‐Associated Circulatory Overload Associated With Splenic Sequestration Management in Sickle Cell Disease
by: Laura S. Duarte, et al.
Published: (2024)

Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype
by: Nate Goldfarb, et al.
Published: (2025)

Pregnancy‐ and Disease‐Related Morbidity Among Medicaid Enrollees With Sickle Cell Disease
by: Mariam Kayle, et al.
Published: (2025)

Influence of Weather on Sickle Cell Disease Vaso‐Occlusive Episodes and Acute Chest Syndrome: A Nationwide Sample Analysis
by: Neha J. Desai, et al.
Published: (2025)

Highlighting Healthcare Disparities in Sickle Cell Disease Management in Resource‐Constrained Settings: A Cross‐Sectional Study in Lebanon
by: Morgan Bou Zerdan, et al.
Published: (2025)

Major ABO Incompatibility in Non‐Myeloablative Hematopoietic Stem Cell Transplant for Sickle Cell Disease—Not an Insurmountable Obstacle
by: Kimberly Ji Eun Chung, et al.
Published: (2025)

The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?
by: Charles T. Quinn, et al.
Published: (2024)

Hemoglobin Richmond Masquerading as Fetal Hemoglobin in a Child With Sickle Cell Disease: A Case Report and Review of the Literature
by: Jordyn Hollander, et al.
Published: (2025)

Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease
by: Akhila Vadivelan, et al.
Published: (2025)

Medication Utilization Among Children With Sickle Cell Disease in the United States
by: Abiodun John Ologunowa, et al.
Published: (2025)

Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease
by: Zachary Abramson, et al.
Published: (2025)

Sickle Cell Disease‐Related Stigma: Quantitative Assessment From India
by: Bontha V. Babu, et al.
Published: (2025)

Clinical Practice Patterns for Discussing Hydroxyurea Initiation With Families of Children With Sickle Cell Disease
by: Aimee K. Hildenbrand, et al.
Published: (2026)

Pulmonary Dysfunction Is Associated With Sleep Study Abnormalities in Children With Sickle Cell Disease: A Multicenter Study
by: Ammar Saadoon Alishlash, et al.
Published: (2026)

Association of Food Insecurity With Disease‐Related Complications and Healthcare Utilization for Patients With Sickle Cell Disease
by: Sharjeel Syed, et al.
Published: (2025)

Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease
by: Rhayane Vitória Lopes, et al.
Published: (2025)

How We Approach Contraception for Adolescents and Young Adults With Sickle Cell Disease
by: Maayan Leroy‐Melamed, et al.
Published: (2025)

Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition
by: Gabriela Ramirez‐Cuebas, et al.
Published: (2025)

The Role of Associated Treatment Factors and Mental Health on Transition From Pediatric to Adult Care for Adolescent/Young Adults With Sickle Cell Disease
by: Caryn R. R. Rodgers, et al.
Published: (2025)

User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease
by: Christina M. Abrams, et al.
Published: (2025)

Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease
by: Jill S. Menell, et al.
Published: (2025)

Welding the Gap on Sickle Cell Education
by: Layla Van Doren, et al.
Published: (2026)

Engaging Parents of Children With Sickle Cell Disease in Shared Decision‐Making for Hydroxyurea: The ENGAGE‐HU Study
by: Aimee K. Hildenbrand, et al.
Published: (2025)

The Protective Effect of Fetal Hemoglobin on Retinal Damage in Sickle Cell Disease Patients: A Correlation With Optical Coherence Tomography, Hematologic Parameters, and Hydroxyurea Treatment
by: Jing Jin, et al.
Published: (2025)

Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues
by: Caroline Vinit, et al.
Published: (2025)

Clinical Features and Outcomes of Pneumococcal Bacteremia in Children With Sickle Cell Disease in the Pneumococcal Conjugate Vaccine Era
by: Marianne E. Yee, et al.
Published: (2025)

Timeliness and Adherence to Opioid Administration Guidelines for Acute Sickle Cell Pain in Pediatric Patients: A Comparison of Pediatric and Adult Emergency Departments
by: Ibrahim Gwarzo, et al.
Published: (2026)

Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis
by: Jeffrey G. Edwards, et al.
Published: (2025)

Comment on: The Protective Effect of Fetal Hemoglobin on Retinal Damage in Sickle Cell Disease Patients: A Correlation With Optical Coherence Tomography, Hematologic Parameters, and Hydroxyurea Treatment
by: Songjie Lu, et al.
Published: (2026)